FOXM1 and cancer: However, unlike in other cancers in which FOXM1 contributes to chemoresistance 51,52,58,59, sufficient improvement of chemosensitivity by FOXM1 inhibition was not observed in the KS-EMPD-1 cells because every cytotoxic agent used in this experiment (5-FU, CDDP, DTX, and PTX) massively reduced viable cell counts.